Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
49.49
-0.10 (-0.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
29
30
Next >
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
December 03, 2023
The one thing these two stocks have in common is tremendous growth prospects.
Via
The Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
Via
The Motley Fool
5 Top Stocks to Buy Before 2024
December 02, 2023
These stocks have room to run -- next year and over the long term.
Via
The Motley Fool
Five Best Performing Stocks Of The Top ETF Of November
December 01, 2023
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way.
Via
Talk Markets
Topics
ETFs
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
December 01, 2023
It's not as long a shot as some might think.
Via
The Motley Fool
Is CRISPR Therapeutics the Best Gene-Editing Stock?
November 22, 2023
The biotech's first-mover advantage bodes well for its long-term prospects.
Via
The Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
December 01, 2023
These stocks offer enormous long-term growth potential.
Via
The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making
November 30, 2023
Uncover investment opportunities with biotech stocks representing firms developing critical breakthroughs in treatments.
Via
InvestorPlace
Cathie Wood's ARK Innovation ETF Achieves 35% Gain In November, Its Best Month Since Inception
November 29, 2023
The ARK Innovation ETF (NYSE:ARKK), managed by renowned investor Cathie Wood, has posted remarkable gains in November, making it the fund’s best-performing month since its launch in 2014.
Via
Benzinga
Topics
ETFs
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
November 29, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.
Via
Benzinga
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
November 28, 2023
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.
Via
InvestorPlace
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
November 28, 2023
These stocks may take off in a market favoring growth.
Via
The Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
November 25, 2023
These innovators should have tremendous long-term growth prospects.
Via
The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
Many biotech stocks offer exciting long-term growth prospects.
Via
The Motley Fool
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
November 20, 2023
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.
Via
Talk Markets
Topics
ETFs
What's Going On With Crispr Therapeutics Stock Monday?
November 20, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday on what appears to be continued momentum from the recent regulatory authorization of the company's
Via
Benzinga
Google’s Bard AI Says These 3 Stocks Will Rise 1,000%
November 20, 2023
Google's Bard has been among the best stock pickers, and thinks these three stocks have quadruple-digit upside potential.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
November 20, 2023
Investment bank analysts are pounding the table on these stocks, but are they right for your portfolio?
Via
The Motley Fool
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?
November 19, 2023
The stock is trading below its peak, reached a couple of years ago.
Via
The Motley Fool
3 Monster Stocks in the Making
November 18, 2023
These stocks could grow much larger over the next few years.
Via
The Motley Fool
Why CRISPR Therapeutics Stock Is Jumping Again Today
November 17, 2023
The stock continues to enjoy momentum from a key regulatory approval.
Via
The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
November 17, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
November 17, 2023
CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
3 Long-Term Growth Stocks Analysts Are Bullish On
November 16, 2023
Here are three long-term growth stocks for your consideration if you’re looking to take a long position in a new name or two.
Via
InvestorPlace
3 Cathie Wood You’ll Regret Not Buying Soon: November 2023
November 16, 2023
Cathie Wood thinks we're out of the woods economically, and these stock picks in her portfolio stand to gain the most in coming months.
Via
InvestorPlace
Why Is NIO Stock Down 5% Today?
November 16, 2023
Nio stock is falling on Thursday as investors react to negative news following the summit between Presidents Xi Jinping and Joe Biden.
Via
InvestorPlace
Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug
November 16, 2023
The drug will sell under the brand name Casgevy in the UK for two blood diseases.
Via
Investor's Business Daily
What's Going On With Crispr Therapeutics Stock Thursday?
November 16, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-
Via
Benzinga
Citi Is Souring on Plug Power (PLUG) Stock
November 16, 2023
Plug Power stock is falling on Thursday after the EV charging company's shares were hit with a downgrade and lowered price target from Citi.
Via
InvestorPlace
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
November 16, 2023
CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.